(Q42945285)

11 November 2017

title

Population based evaluation of a multi-parametric steroid profiling on administered endogenous steroids in single low dose (English)

1 reference

11 November 2017

author name string

Pieter Van Renterghem

1

1 reference

11 November 2017

Peter Van Eenoo

2

1 reference

11 November 2017

Frans T. Delbeke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20688095

17 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20688095

17 June 2024

publication date

3 August 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0039128X10001765?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

https://api.elsevier.com/content/article/PII:S0039128X10001765?httpAccept=text/plain

17 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

17 June 2024

1 reference

11 November 2017

volume

75

1 reference

11 November 2017

issue

13-14

1 reference

11 November 2017

page(s)

1047-1057

1 reference

Testosterone prohormone supplements

11 November 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Over-the-counter anabolic steroids 4-androsten-3,17-dione; 4-androsten-3beta,17beta-diol; and 19-nor-4-androsten-3,17-dione: excretion studies in men.

17 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation

17 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Evaluating an abnormal urinary steroid profile

17 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Detection of testosterone misuse: comparison of two chromatographic sample preparation methods for gas chromatographic-combustion/isotope ratio mass spectrometric analysis

17 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Gas chromatography/combustion/isotope-ratio mass spectrometry analysis of urinary steroids to detect misuse of testosterone in sport

17 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Doping: a paradigm shift has taken place in testing

17 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Testosterone and doping control

17 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Searching for new markers of endogenous steroid administration in athletes: "looking outside the metabolic box".

17 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

The detection of androstenedione abuse in sport: a mass spectrometry strategy to identify the 4-hydroxyandrostenedione metabolite

17 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Evaluation of human hepatocyte incubation as a new tool for metabolism study of androstenedione and norandrostenedione in a doping control perspective

17 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Influence of oral dehydroepiandrosterone (DHEA) on urinary steroid metabolites in males and females

17 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Metabolism of dehydroepiandrosterone

17 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Criteria to indicate testosterone administration

17 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Urinary excretion of steroid metabolites after chronic androstenedione ingestion

17 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes

17 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Validation of an extended method for the detection of the misuse of endogenous steroids in sports, including new hydroxylated metabolites

17 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Testing for natural and synthetic anabolic agents in human urine

17 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.

17 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Oral administration of dehydroepiandrosterone to healthy men: alteration of the urinary androgen profile and consequences for the detection of abuse in sport by gas chromatography-mass spectrometry

17 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

7-Hydroxydehydroepiandrosterone epimers in the life span

17 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

The effect of oral dehydroepiandrosterone (DHEA) on the urine testosterone/epitestosterone (T/E) ratio in human male volunteers.

17 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

Oral dehydroepiandrosterone supplementation can increase the testosterone/epitestosterone ratio

17 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.STEROIDS.2010.06.013

17 June 2024

Identifiers

1 reference

11 November 2017

1 reference